Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02101515 · ClinicalTrials.gov registry record · NA
Randomized Control Trial of Second Stage of Labor
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT02101515 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 78 participants.
The verdict
NCT02101515, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The hypothesis of this study is that extending the second stage of labor beyond current American College of Obstetricians and Gynecologists suggestions can reduce the cesarean delivery rate. The cesarean delivery rate in the United States is around 30 percent. This is a number that continues to be increasing over the last few decades and will continue to climb. Each subsequent cesarean section puts the mother and baby at increased risk for postpartum hemorrhage, bowel and bladder injury, abnormal placentation, febrile morbidity and death. The most common reason for a cesarean delivery is a repeat cesarean delivery. One way to reduce this number is to prevent the first cesarean delivery. The aim of this study is evaluate if extending the second stage of labor affects the cesarean delivery rate and subsequent perinatal morbidity.
Interventions
- OTHER Length of Second Stage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02101515
The ClinicalTrials.gov registry entry for NCT02101515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Length of Second Stage is the first listed.
NCT02101515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02101515 about?
NCT02101515 is a clinical study titled "Randomized Control Trial of Second Stage of Labor". The hypothesis of this study is that extending the second stage of labor beyond current American College of Obstetricians and Gynecologists suggestions can reduce the cesarean delivery rate. The cesarean delivery rate in the United States is around 30 percent. This is a number that continues to be i...
What is the current status of trial NCT02101515?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2014-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02101515?
The interventions under investigation include: Length of Second Stage (OTHER).
Who is sponsoring clinical trial NCT02101515?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.